Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

被引:0
|
作者
Gonzalez, Luis Alonso [1 ]
Harvey, Guillermina B. [2 ]
Quintana, Rosana [3 ]
Pons-Estel, Guillermo J. [3 ]
Ugarte-Gil, Manuel F. [4 ,5 ]
Vasquez, Gloria [1 ]
Catoggio, Luis J. [6 ]
Garcia, Mercedes A. [7 ]
Borba, Eduardo F. [8 ]
Silva, Nilzio A. Da [9 ]
Brenol, Joao C. Tavares [10 ,11 ]
Toledano, Marlene Guibert [12 ]
Massardo, Loreto [13 ]
Neira, Oscar [14 ]
Pascual-Ramos, Virginia [15 ]
Amigo, Mary-Carmen [16 ]
Barile-Fabris, Leonor A. [17 ]
Torre, Ignacio Garcia De La [18 ]
Alfaro-Lozano, Jose [5 ]
Segami, Maria I. [19 ]
Chacon-Diaz, Rosa [20 ]
Esteva-Spinetti, Maria H. [21 ]
Iglesias-Gamarra, Antonio [22 ]
Alarcon, Graciela S. [23 ,24 ]
Pons-Estel, Bernardo A.
机构
[1] Univ Antioquia, Fac Med, Dept Med Interna, Secc Reumatol, Medellin, Colombia
[2] Univ Nacl Rosario, Inst Invest Teor & Aplicadas Escuela Estadist, Rosario, Santa Fe, Argentina
[3] Grp Orono Ctr Reg Enfermedades Autoinmunes & Reuma, Rosario, Argentina
[4] Univ ESAN, Lima, Peru
[5] Hosp Nacl Guillermo Almenara Irigoyen, Rheumatol Dept, EsSalud, Lima, Peru
[6] Hosp Italiano Buenos Aires, Rheumatol Sect, Buenos Aires, Argentina
[7] HIGA San Martin La Plata, Serv Reumatol, La Plata, Argentina
[8] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Rheumatol Div, Sao Paulo, Brazil
[9] Univ Fed Goias, Fac Med, Goiania, Brazil
[10] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[11] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[12] Hosp Ctr Invest Med Quirurg, CIMEQ, Havana, Cuba
[13] Univ San Sebastian, Fac Med & Ciencia, Ctr Biol Celular & Biomed, Concepcion, Chile
[14] Univ Chile, Hosp Salvador, Secc Reumatol, Santiago, Chile
[15] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, Mexico
[16] Ctr Med ABC, Reumatol, Mexico City, Mexico
[17] Hosp Angeles Del Pedregal, Mexico City, Mexico
[18] Secretaria Salud Jalisco, Hosp Gen Occidente, Dept Inmunol & Reumatol, Zapopan, Jalisco, Mexico
[19] Hosp Nacl Edgardo Rebagliati Martins, EsSalud, Lima, Peru
[20] Hosp Univ Caracas, Ctr Nacl Enfermedades Reumat, Caracas, Venezuela
[21] Hosp Cent San Cristobal, Dept Med, Serv Reumatol, San Cristobal, Venezuela
[22] Univ Nacl Colombia, Dept Med Interna, Unidad Reumatol, Bogota, Colombia
[23] Univ Alabama Birmingham, Marnix E Heersink Sch Med, Dept Med, Birmingham, AL USA
[24] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru
关键词
Systemic lupus erythematosus; Autoimmune thrombocytopenia; Predictors; Organ damage; Mortality; CLINICAL-IMPLICATIONS; HEMOLYTIC-ANEMIA; REVISED CRITERIA; DISEASE; CLASSIFICATION; MULTICENTER; MORTALITY; PREVALENCE; VALIDATION; DERIVATION;
D O I
10.1016/j.semarthrit.2024.152568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the predictors of the occurrence of severe thrombocytopenia and its impact on damage accrual and mortality in SLE patients. Methods: Factors associated with time to severe thrombocytopenia (platelet count <= 20,000/mm3) occurring from the onset of SLE symptoms were assessed by Cox proportional hazards regressions. The association of severe thrombocytopenia with mortality was evaluated by logistic regression analyses while its impact on damage was by negative binomial regression. Results: Of 1,217 patients, 33 (2.7%) developed severe thrombocytopenia over a mean (SD) follow-up time of 5.9 (3.6) years. The median time from the onset of SLE symptoms to severe thrombocytopenia occurrence was 22 months (IQR 8.7-62.0). Mestizo (60.6%) was the predominant ethnic group, followed by Caucasian (27.3%), while African Latin American exhibited the lowest frequency (12.1%). By multivariable analysis, Mestizo ethnicity (HR 2.67, 95% CI 1.12-6.37, p = 0.027), and autoimmune hemolytic anemia (AIHA) at baseline (HR 3.99; 95% CI 1.05-15.19, p = 0.042) were associated with a shorter time to the occurrence of severe thrombocytopenia while middle/high socioeconomic status (HR 0.23; 95% CI 0.08-0.69, p = 0.008) was associated with a longer time. Severe thrombocytopenia contributed neither to damage nor to mortality. Conclusions: Severe thrombocytopenia occurs during the early course of SLE. Mestizo ethnicity and AIHA at baseline emerged as independent predictors of a shorter time to severe thrombocytopenia occurrence while a middle/high socioeconomic status seems to be protective against its occurrence. Damage and mortality did not seem to be impacted by the occurrence of severe thrombocytopenia.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort
    Ines, Luis
    Silva, Candida
    Galindo, Maria
    Lopez-Longo, Francisco J.
    Terroso, Georgina
    Romao, Vasco C.
    Rua-Figueroa, Inigo
    Santos, Maria J.
    Pego-Reigosa, Jose M.
    Nero, Patricia
    Cerqueira, Marcos
    Duarte, Catia
    Miranda, Luis C.
    Bernardes, Miguel
    Goncalves, Maria J.
    Mourino-Rodriguez, Coral
    Araujo, Filipe
    Raposo, Ana
    Barcelos, Anabela
    Couto, Maura
    Abreu, Pedro
    Oton-Sanchez, Teresa
    Macieira, Carla
    Ramos, Filipa
    Branco, Jaime C.
    Silva, Jose A. P.
    Canhao, Helena
    Calvo-Alen, Jaime
    ARTHRITIS CARE & RESEARCH, 2015, 67 (08) : 1180 - 1185
  • [42] PReS-FINAL-2356: A comparison of the American college of rheumatology and the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus using data from the uk juvenile systemic lupus erythematosus cohort study
    O Lloyd
    E Heaf
    T Morgan
    C Roberts
    L McCann
    MW Beresford
    Pediatric Rheumatology, 11 (Suppl 2)
  • [43] Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
    Hernandez Cruz, B.
    Alonso, F.
    Calvo Alen, J.
    Pego-Reigosa, J. M.
    Lopez-Longo, F. J.
    Galindo-Izquierdo, M.
    Olive, A.
    Tomero, E.
    Horcada, L.
    Uriarte, E.
    Erausquin, C.
    Sanchez-Atrio, A.
    Montilla, C.
    Santos Soler, G.
    Fernandez-Nebro, A.
    Blanco, R.
    Rodriguez-Gomez, M.
    Vela, P.
    Freire, M.
    Diez-Alvarez, E.
    Boteanu, A. L.
    Narvaez, J.
    Martinez Taboada, V.
    Ruiz-Lucea, E.
    Andreu, J. L.
    Fernandez-Berrizbeitia, O.
    Hernandez-Beriain, J. A.
    Gantes, M.
    Perez-Venegas, J. J.
    Ibanez-Barcelo, M.
    Pecondon-Espanol, A.
    Marras, C.
    Bonilla, G.
    Castellvi, I.
    Moreno, M.
    Raya, E.
    Quevedo Vila, V. E.
    Vazquez, T.
    Ruan, J. Ibanez
    Munoz, S.
    Rua-Figueroa, I.
    LUPUS, 2020, 29 (01) : 27 - 36
  • [44] Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients.
    Fredeau, Lisa
    Courvoisier, Delphine S.
    Mehdi, Raphael Ait
    Ingen-Housz-Oro, Saskia
    Mahe, Emmanuel
    Costedoat-Chalumeau, Nathalie
    Arnaud, Laurent
    Frances, Camille
    Mathian, Alexis
    Jachiet, Marie
    Amoura, Zahir
    Bouaziz, Jean David
    Chasset, Francois
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 551 - 559
  • [45] A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort
    Ugarte-Gil, Manuel Francisco
    Gamboa-Cardenas, Rocio Violeta
    Reategui-Sokolova, Cristina
    Pimentel-Quiroz, Victor Roman
    Medina, Mariela
    Elera-Fitzcarrald, Claudia
    Rodriguez-Bellido, Zoila
    Pastor-Asurza, Cesar Augusto
    Perich-Campos, Risto Alfredo
    Alarcon, Graciela S.
    LUPUS SCIENCE & MEDICINE, 2023, 10 (01):
  • [46] Probabilistic survival modeling in health research: an assessment using cohort data from hospitalized patients with COVID-19 in a Latin American city
    Passarelli-Araujo, Hisrael
    Passarelli-Araujo, Hemanoel
    Pescim, Rodrigo R.
    Olak, Andre S.
    Susuki, Aline M.
    Tomimatsu, Maria F. A. I.
    Volce, Cilio J.
    Neves, Maria A. Z.
    Silva, Fernanda F.
    Narciso, Simone G.
    Paoliello, Monica M. B.
    Pott-Junior, Henrique
    Urbano, Mariana R.
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2023, 86 (07): : 217 - 229
  • [47] Hematological factors associated with immunity, inflammation, and metabolism in patients with systemic lupus erythematosus: Data from a Zhuang cohort in Southwest China
    Lao, Xiaoxia
    Ma, Liping
    Ma, Qingwei
    Ma, Qiaorong
    Yang, Zhige
    Guo, Lingxiao
    Nong, Wenzheng
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (06)
  • [48] Quality of life, self-reported outcomes and impact of education among people with moderate and severe hemophilia A: An integrated perspective from a Latin American country
    Torres, Liliana
    Penuela, Oscar
    Forero, Maria del Rosario
    Satizabal, Juan
    Salazar, Ximena
    Benavides, Diana
    Gamarra, Raul
    Rivera, Marcela
    Vizcaya, David
    Franco, Juan-Sebastian
    PLOS ONE, 2023, 18 (07):
  • [49] Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study
    Montero-Arias, Felicia
    Herrera Garcia, Jose Carlos
    Pacheco Gallego, Manuel
    Anton Antila, Martti
    Schonffeldt, Patricia
    Javier Mattarucco, Walter
    Tejado Gallegos, Luis Fernando
    Beekman, Maarten J. H., I
    JOURNAL OF ASTHMA, 2023, 60 (03) : 574 - 587
  • [50] Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D
    Sanchez, M. L.
    McGwin, G., Jr.
    Duran, S.
    Fernandez, M.
    Reveille, J. D.
    Vila, L. M.
    Alarcon, G. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (01) : 64 - 71